News

      September 3, 2021 Event

      Have you missed Obliques’ presentation

      during the Pareto Securities’ Healthcare Conference 2021?

      Read more

      September 1, 2021 News

      Our Founder & CEO Prof. Owe Orwar has been named a winner

      in the CEO Today Healthcare Awards for 2021 by CEO Today Magazine.

      Read more

      August 30, 2021 Event

      For the 1st Neuropathic Pain Therapeutics Summit

      our Head of Discovery & Preclinical R&D- Ion Channel Target in Pain – Daniela Papadia was invited as Expert Speaker.

      Read more

      June 18, 2021 News

      Annual General Meeting On Wednesday the 15th of June 2021,

      we held our Annual General Meeting to conclude our year and discuss about the future. Exciting time.

      Read more

      April 26, 2021 News

      The prestigious Shanghai ranking gives at Karolinska Institutet

      the fifth position in the world of the best Departments of Pharmacology worldwide.

      Read more

      April 19, 2021 News

      Science Advances, has published a research article

      describing our proteomics technology AbiProt®, a high-tech antibody discovery approach with the potential to bring several novel antibody medicines to large patient populations in multiple disease areas.

      Read more

      March 11, 2021 Event

      On March 10th 2021, Professor Owe Orwar, CEO

      presented Oblique Therapeutics AB at Carnegie Nordic Virtual Healthcare Seminar 2021.

      Read more

      November 18, 2020 News

      Oblique Therapeutics AB raises 98 MSEK

      in a private placement investment round.

      Read more

      October 19, 2020 News

      This is our first Abiprot patent.

      We hope that many more will follow.

      Read more

      October 8, 2020 News

      Oblique Therapeutics AB together with collaborators

      at Sahlgrenska University Hospital (Gothenburg) and Karolinska Institutet (Stockholm) has been granted 5MSEK.

      Read more
      1 2 3